Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Gynecol Oncol. 2019 Jul 25;154(3):524–530. doi: 10.1016/j.ygyno.2019.07.004

Figure 2:

Figure 2:

Multiplex ELISA analyses of the dynamic changes in IL-6 (A), and IL-8 (B) in ovarian cancer patients who had complete response (CR), partial response (PR), or stable (SD)/progressive disease (PD) with chemotherapy during the study period.